[[abstract]]Background: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease now, and it is comprised of non-alcoholic fatty liver and non-alcoholic steatohepatitis (NASH). When NASH is present, it can progress to fibrosis, cirrhosis and hepatocellular carcinoma and result in liverrelated death . Currently, no FDA-approved pharmacotherapy for this disease is available . Cannabinoid receptor 1 (CB1) is highly induced in human cirrhotic samples and activated hepatic stellate cells, and it contributes to the pathogenesis of acute phase liver injury, fibrogenesis, alcoholic-induced liver disease, NAFLD and cardiovascular associated cirrhosis . Besides, endocannabinoids and CB1 receptors are also highly activated in obesity...
Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has...
Although the mortality rates of cirrhosis are underestimated, its socioeconomic burden has demonstra...
<div><p>Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simpl...
[[abstract]]Background: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease n...
Nonalcoholic fatty liver disease (NAFLD) is comprised of nonalcoholic fatty liver (NAFL) and nonalco...
International audiencePrevalence of non-alcoholic steatohepatitis (NASH) rises steadily in Western c...
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver morbidity and mortality with no ...
SummaryOver the last decade, the endocannabinoid system has emerged as a pivotal mediator of acute a...
In high-fat diet (HFD) induced nonalcoholic fatty liver disease (NAFLD), there is an increase in the...
Endocannabinoids are lipid mediators of the same cannabinoid (CB) receptors that medi-ate the effect...
We used rimonabant to investigate the role of CB1 receptor on hepatic FFAs profile during NAFLD. Mal...
Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis a...
International audienceIt is well established that inactivation of the central endocannabinoid system...
: Obesity and nonalcoholic fatty liver disease (NAFLD) constitute global and growing epidemics that ...
Nonalcoholic fatty liver disease (NAFLD) develops when the liver is unable to oxidize or export exce...
Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has...
Although the mortality rates of cirrhosis are underestimated, its socioeconomic burden has demonstra...
<div><p>Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simpl...
[[abstract]]Background: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease n...
Nonalcoholic fatty liver disease (NAFLD) is comprised of nonalcoholic fatty liver (NAFL) and nonalco...
International audiencePrevalence of non-alcoholic steatohepatitis (NASH) rises steadily in Western c...
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver morbidity and mortality with no ...
SummaryOver the last decade, the endocannabinoid system has emerged as a pivotal mediator of acute a...
In high-fat diet (HFD) induced nonalcoholic fatty liver disease (NAFLD), there is an increase in the...
Endocannabinoids are lipid mediators of the same cannabinoid (CB) receptors that medi-ate the effect...
We used rimonabant to investigate the role of CB1 receptor on hepatic FFAs profile during NAFLD. Mal...
Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis a...
International audienceIt is well established that inactivation of the central endocannabinoid system...
: Obesity and nonalcoholic fatty liver disease (NAFLD) constitute global and growing epidemics that ...
Nonalcoholic fatty liver disease (NAFLD) develops when the liver is unable to oxidize or export exce...
Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has...
Although the mortality rates of cirrhosis are underestimated, its socioeconomic burden has demonstra...
<div><p>Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simpl...